Over the next 10-20 years, a pessimistic prognosis considers pandemic scenario for type 2 diabetes mellitus, neurodegenerative disorders and some types of cancer followed by the economic disaster of healthcare systems in a global scale. Well-recognised deficits of currently provided medical services result from the delayed 'disease care'. Herewith EPMA releases the long-term strategies for the effective promotion of predictive, preventive and personalised medicine (PPPM) considered as the medicine of the future. Under the EPMA-umbrella, an international forum of currently 45 countries is actively contributing to the development and implementation of the innovative PPPM concepts. EPMA is open for collaboration with other leading European and global professional networks relevant for the effective promotion of PPPM in sciences and practical implementation.
Unpredictable, unpreventable and impersonal medicine: deficits of current healthcare
Over the next 10-20 years, a pessimistic prognosis considers pandemic scenario for an increasing number of chronic diseases, such as type 2 diabetes mellitus, neurodegenerative disorders, some types of cardiovascular diseases and cancer followed by the economic disaster of healthcare systems in a global scale. Well-recognised deficits of current healthcare is the delayed 'disease care' with all negative consequences such as the low efficacy of medical services, decreased quality of the patient life, frequent hospitalisation and increasing economical and societal burden.
'We have the knowledge for disaster reduction, what we need is the action' [1] .
PPPM-medicine of the future and evidence-based platform to advance healthcare Advanced healthcare promotes the paradigm change from delayed interventional to predictive medicine tailored to the person, from reactive to preventive medicine and from disease to wellness. Predictive, preventive and personalised medicine (PPPM) is the new integrative concept in healthcare sector that enables to predict individual predisposition before onset of the disease, to provide targeted preventive measures and create personalised treatment algorithms tailored to the person. Integrative approach by PPPM is considered as the medicine of the future. The cost-effective management of health promotion and disease care implements the innovation by PPPM in modernisation of medical services. Being at the forefront of the global efforts, the European Association for Predictive, Preventive and Personalised Medicine (EPMA, http://www.epmanet.eu/) promotes the integrative concept of PPPM amongst healthcare stakeholders, governmental institutions, educators, funding bodies, patient organisations and in the public domain [2] . Under the EPMA-umbrella, an international forum of currently 45 countries is actively contributing to the development and implementation of the innovative PPPM concepts (see Figure 1 ) worldwide. The main structures altogether create a consolidated scientific, technological and educational platform and elaborate the long-term strategies of the association, namely: 
Long-term strategies of the European Association for Predictive, Preventive and Personalised Medicine
Prioritised medical fields listed and shortly described below have been approved as being of strategic interests of the association. The study was approved by the EPMA BOARD of Directors, Group of Associate editors responsible for individual sections, EPMA Institutional members and EPMA Industrial Advisory Board. Consequent realisation will be organised by the EPMA using following instruments:
➢ multilateral professional and international collaborations, ➢ excellent research activities, ➢ high-quality publications (The EPMA Journal, EPMA Book-Series and other instruments),
➢ scientific projects responding to the calls of the 'Horizon 2020' (and other appropriate national and international programmes), international meetings (EPMA Summits/World Congresses and other appropriate forums) [3] , ➢ implementation of the evidence-based research achievements for an effective advancing of healthcare by innovative medical services (creation and qualification of PPPM centres of excellence), ➢ PPPM-related education for both professionals and general population, ➢ effective career promotion of young professionals creating a highly qualified professional elite for the realisation of PPPM objectives via new generations of experts in the EU and global scale. Mozaffari, USA) Oral/dental health contributes to the overall health and well-being of everybody. A growing body of evidence demonstrates that the manifested dental and oral pathologies are linked to the increased risk of various diseases including heart and lung disease, vascular pathologies, stroke, diabetes mellitus, neurological disorders, pre-term birth and even some types of cancer, amongst others. Further, certain oral symptoms are considered as the early indicator of a spectrum of the mental disorders such as anorexia, bulimia, anxiety and depression. On the other hand, dental diseases themselves may be caused by acute and chronic systemic disorders such as diabetes mellitus. Whilst an association between oral/dental diseases and systemic disorders is well established, the cause-and-effect relationships in these conditions are poorly understood, an investigation of which is a prerequisite for predictive, preventive and personalised dental medicine [20] [21] [22] Coelho, Portugal) This section involves a multidisciplinary approach that ranges from the application of innovative active therapeutic medicines to advanced methods for controlled delivery. Particular attention is paid to outstanding developments involving structurebiological activity relationships in different areas of interest for this topic, such as: stem cells; rational drug design, new (co)polymers; creation of tailor-made drug delivery systems; incorporation of target molecules to the polymeric structures; encapsulation of approved drugs with the polymers; preparation and characterisation of nanoparticles for in vivo diagnostics and treatment; and evaluation and validation of new systems in vitro and in vivo studies [43] [44] [45] [46] . 21.Design (responsible editors: Antony Kent, UK, and Guglielmo M. Trovato, Italy) The specific challenge for multidisciplinary communication is the design of media to facilitate effective interaction amongst professional groups in PPPM. These groups currently 'speak different languages' which reinforce each group's professional perspective and frequently underestimates the added value of the transfer of products between disciplines. The specific output of this designing activity is the so-called 'professional interactome' and the representation of complex networks of information. The interactome represents the most optimal model of healthcare organisation designed specifically for the implementation of an effective interaction amongst professional groups in PPPM that creates the main focus of this section. Recognising the need for engagement and to enhance an patient's ease of access to, and usability of, services and products, the design principles of envisioning and empathy, ergonomics and prototyping will be applied to the conceptualisation and development of personalised services (service and experience design) and personal medical devices (product design). Since 'style in the life' is one of the most important factors affecting health status and its perception, particularly in youngsters, design in the wider sense of the concept and, namely, fashion's trends strongly influences media, health-related behaviours, body size, shape and appearance perception. For these reasons, multidimensional assessment and intervention aimed to favourable modifications of lifestyles should include the awareness that urban, home and work design, even clothing and fashion and related industries, can be addressed to the enhancement of PPPM intervention [47] -creation of expert recommendations for advanced healthcare -collaborative promotion of innovative medical fields and the philosophy of integrative medicine -collaborative development of scientific projects dedicated to translational medicine and practical application of innovative technologies in routine medical practice -networking of institutional members in Europe and worldwide -mutual enrichment of the long-term strategies and outlook in PPPM by concepts development and regular publishing of position articles in both journals-The EPMA Journal and European Radiology -mutual support of educational and training programmes by inviting experts and providing expertise related to diverse branches of PPPM -creation of innovative didactic materials for PPPM-related educational and training programmes -collaborative development of granting strategies and synergies in setup of innovative projects related to PPPM, e.g. in the European 'Horizon 2020' -creation of specialised EPMA/ESR workshops at the regular EPMA World Congresses and ESR Congresses -Mutual support in publicity (website, public relation, etc.).
European Federation of Clinical Chemistry and Laboratory Medicine (EFLM, www.efcclm.org); EFLM provides European leadership in clinical chemistry and laboratory medicine. Both EPMA and EFLM consider the integrative approach by PPPM as the medicine of the future. In furtherance of their mutual interest in advancing the healthcare paradigm from reactive to predictive, preventive and personalised medicine and in laboratory medicine as the integrating element in PPPM, the two organisations recognise the added value of working together and initiate the establishment of the joint Working Group (WG). The strategic document about EPMA/EFLM professional synergies recently has been published in The EPMA Journal to define clear priorities of the collaboration [36] .
European Society of Predictive Medicine (EUSPM, www.euspm.org); EPMA and EUSPM are joining the efforts for the predictive diagnostics, targeted preventive measures and personalised patient treatment in the European healthcare. Professional synergies are developed, and bilateral support is provided concerning all scientific, granting, publication, practical application and any other network-related activities.
European Depression Association (EDA, www.europeandepressionday.com); EDA is interested in professional collaboration with the EPMA focusing specifically on predictive diagnostics, targeted prevention and advanced person-centred approaches for the most optimal treatment of depression as the stratified patient cohort.
European, Middle-Eastern and African Society for Biopreservation and Biobanking (ESBB, www.esbb. org); Designed as being reliable for advanced healthcare services, biobanking considers the interests of all parties involved in the research and business. International biobanking is in a focus of both EPMA and ESBB creating the solutions to the below listed unmet needs, namely
How can local and international barriers be broken down to unify international biopreservation technologies, sample collections and databases? Who carries the role to promote in the process of biobanking internationalisation? Who should cover the costs of the internationally accessible systems? Who is allowed to legally use these international biobanks once they are created? Who could be nominated as the end user of the data collected?
EPMA is open for collaboration with other leading European and global professional networks relevant for the effective promotion of PPPM.
